Vascular interventional radiology (VIR) review

Learn about how the Medical Benefits Schedule (MBS) Review Advisory Committee (MRAC) is reviewing VIR MBS items.

About the review

This review aims to align the MBS with current and evidence-based clinical use of interventional radiology and interventional neuroradiology.

We referred this review to the MRAC following the MBS Review Taskforce’s review of vascular items and further consultation with the sector.

Who we work with

The MRAC established a working group to lead this review and report back to the full committee on its findings.

See the members page for the list of current working group members.

Why the review is important

When we make changes to MBS items the MRAC will do a review about 24 months after to analyse the impact of these changes. This is called a post-implementation review. 

Post-implementation reviews provide an opportunity to see whether the item changes:

  • achieve their intended outcomes
  • have any impacts to patients access and health outcomes.


The working group is developing a draft report with recommendations for a proposed series of new or amended MBS items.

The report will be available for feedback through an open consultation process later in the 2024.

Activities to date

5 August 2022The MRAC agreed to establish a working group to lead the review 
February 2023The working group was established 
March 2023 to February 2024The working group held 4 meetings


Vascular interventional radiology (VIR) review contact

Contact us with questions about the vascular interventional radiology (VIR) review.
Date last updated:

Help us improve

If you would like a response please use the enquiries form instead.